VaramirStart free · no cardSign in
ZYME as of Nov 1 · 00:20 ET
ZYMENasdaqPharmaceutical Preparations

Zymeworks Inc. · Brief

Next report

4 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±16.8%
avg realized
±4.1%
Mar 5 '25±12.4%▼−7.97%×0.64
May 8 '25±12.1%▼−0.13%×0.01
Aug 7 '25±14.8%▼−1.15%×0.08
Q3 FY25±26.9%▼−8.04%×0.30
Jan 12 '26±9.9%▲+3.28%×0.33
Q1 FY26±12.9%▲+0.09%×0.01
May 7 '26±25.0%▼−10.19%×0.41
Q2 FY26±20.7%▲+1.77%×0.09
quarterimplied−30%0+30%realized×
Q2 FY26±20.7%▲+1.77%×0.09
May '26±25.0%▼−10.19%×0.41
Q1 FY26±12.9%▲+0.09%×0.01
Jan '26±9.9%▲+3.28%×0.33
Q3 FY25±26.9%▼−8.04%×0.30
Aug '25±14.8%▼−1.15%×0.08
2 older reports
May '25±12.1%▼−0.13%×0.01
Mar '25±12.4%▼−7.97%×0.64
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

12disclosed supplier and customer ties reported in company SEC filingsSEC filings
202managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

8 of 8recent reports where the move came in under the options implied rangeEarnings history
0.04%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

ZYME report session

Customers 1

JAZZJazz×0.30
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 238-KMaterial agreement: Collaboration and License Agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.Source
Oct 22impliedImplied move: ±11.8% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.